Skip Nav Destination
Issues
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Amaya Lopez-Pascual; Joan S. Russo-Cabrera; Nuria Ardaiz; Tiffany Palmer; Anne-Renee Graham; Iker Uriarte; Celia Gomar; David Ruiz-Guillamon; Maria U. Latasa; Maria Arechederra; Antonio Fontanellas; Maria J Monte; Jose J.G. Marin; Carmen Berasain; Carlos L. del Rio; Maite G. Fernandez-Barrena; Paolo G.V. Martini; Joshua R. Schultz; Pedro Berraondo; Matias A. Avila
Clin Sci (Lond) (2024) 138 (20): 1265–1284.